Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for KRISTALLINE FORMEN VON N-[4-(CHLORDIFLUORMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL] -5-( 1H-PYRAZOL-5-YL) PYRIDIN-3-CARBOXAMID
Details for 2020726959
Up to date per 15.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2020726959
Title / Product Name
KRISTALLINE FORMEN VON N-[4-(CHLORDIFLUORMETHOXY)PHENYL]-6-[(3R)-3-HYDROXYPYRROLIDIN-1-YL] -5-( 1H-PYRAZOL-5-YL) PYRIDIN-3-CARBOXAMID
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2020726959
EP Publication Number
3969117
E-Number
1900950
Language
EN
PCT Number
IB20054628
Publication Date
23.03.2022 A
25.03.2026 B1
Registration Date
25.03.2026
AT Publication Date
15.04.2026
Application Date
15.05.2020
Registration Number
-
Priorities
16.05.2019
US
201962848857 P
18.12.2019
US
201962949599 P
IPC
A61P 35/00 20060101AFI20201120BHEP
Maximum Duration of Protection
15.05.2040
Owner
Novartis AG
Lichtstrasse 35
4056 Basel
CH
Representative
No representatives present
Inventor
DODD, Stephanie Kay
c/o Novartis Institutes for Bio Medical Research, Inc., 250 Massachusetts Avenue,
Cambridge, New Jersey 02139
US
GRANDEURY, Arnaud
c/o Novartis Pharma AG Postfach
4002 Basel
CH
ROUSAKI, Evgenia
c/o Novartis Pharma AG Postfach
4002 Basel
CH
SUFFERT, Emmanuel
c/o Novartis Pharma AG Postfach
4002 Basel
CH
Information about Fees
Click here to load the fees